Eli Lilly and Company
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Eli Lilly and Company based on listed parameters only.
The articles listed below published by authors from Eli Lilly and Company, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
Advanced Functional Materials |
1 | 0.00 |
|
Analytical Chemistry |
3 | 1.38 |
|
Angewandte Chemie International Edition |
2 | 0.46 |
|
Annals of Neurology |
1 | 0.27 |
|
Blood |
1 | 0.94 |
|
Brain |
1 | 0.07 |
|
Cell Metabolism |
1 | 1.00 |
|
Chemical Science |
1 | 0.33 |
|
Clinical Infectious Diseases |
1 | 0.04 |
|
Diabetes Care |
7 | 5.07 |
|
Environmental Science and Technology |
1 | 0.17 |
|
Hepatology |
2 | 0.13 |
|
JAMA: The Journal of the American Medical Association |
5 | 2.63 |
|
Journal of Clinical Endocrinology & Metabolism |
3 | 1.67 |
|
Journal of Clinical Investigation |
1 | 0.13 |
|
Journal of Clinical Oncology |
1 | 0.19 |
|
Journal of Hepatology |
1 | 0.14 |
|
Journal of the American Academy of Dermatology |
1 | 0.44 |
|
Journal of the American Chemical Society |
3 | 0.73 |
|
Molecular Psychiatry |
1 | 0.10 |
|
Nature |
1 | 0.03 |
|
Nature Biotechnology |
1 | 0.03 |
|
Nature Communications |
8 | 1.13 |
|
Nature Medicine |
2 | 0.79 |
|
Organic Letters |
1 | 0.25 |
|
Proceedings of the National Academy of Sciences of the United States of America |
1 | 1.00 |
|
The Lancet |
6 | 2.95 |
|
The Lancet Diabetes & Endocrinology |
2 | 0.98 |
|
The Lancet Oncology |
1 | 0.21 |
|
The New England Journal of Medicine |
9 | 3.76 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.